Pharming Group NV Aktie - PHGN

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

0,9355

Gebot

0,9265

Fragen

0,9355

Volumen

0,9355 Tagesbereich 0,9355

0,639 52-Wochen-Bereich 1,094

Handelsende

0,937

Handelsbeginn

0,9355

Letzte Trade

0.9355

Letzter Handelszeitpunkt

08:01:03

Durchschnittliches Volumen (3 Mio.)

49.864

Finanzvolumen

VWAP

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders Leiden, the Netherlands, June 11, 2025: Pharming Group N.V...

Pharming Group to participate in June investor conferences

Pharming Group to participate in June investor conferences Leiden, the Netherlands, May 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext...

Pharming Group reports first quarter 2025 financial results and provides business update

Pharming Group reports first quarter 2025 financial results and provides business update First quarter 2025 total revenues increased by 42% to...

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director Leiden, the...

Pharming Group to report first quarter 2025 financial results on May 8

Pharming Group to report first quarter 2025 financial results on May 8 Leiden, the Netherlands, April 24, 2025: Pharming Group N.V. (“Pharming”...

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS For media and investors only Joenja® is the...

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F Leiden, the Netherlands, April 3, 2025: Pharming Group N.V...

Pharming Group to participate in April investor conferences

Pharming Group to participate in April investor conferences Leiden, the Netherlands, March 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext...

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune...

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update Full year 2024 total revenues increased by...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.0665	-6.63672654691	1.002	1.0189999	0.929	33837	0.97413327	DE
4	-0.0065	-0.690021231423	0.942	1.094	0.911	47596	0.99984733	DE
12	0.0955	11.369047619	0.84	1.094	0.66	49864	0.86604656	DE
26	0.126	15.5651636813	0.8095	1.094	0.66	43742	0.86252573	DE
52	0.1625	21.021992238	0.773	1.094	0.639	45901	0.8104879	DE
156	-0.2425	-20.5857385399	1.178	1.311	0.639	48327	0.92800221	DE
260	-0.2425	-20.5857385399	1.178	1.311	0.639	48327	0.92800221	DE

PHGN - Frequently Asked Questions (FAQ)

What is the current Pharming Group NV share price?

The current share price of Pharming Group NV is 0,9355 €

What is the 1 year trading range for Pharming Group NV share price?

Pharming Group NV has traded in the range of 0,639 € to 1,094 € during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
Z620Trillion Energy International Inc	0,0279 € (16,74%)	206,5k
ET9Circle Internet Group Inc	202,00 € (16,09%)	18,46k
42FBAIML Innovations Inc	0,0472 € (9,26%)	8,48k
ULCUnited Labels	1,48 € (8,82%)	10
7111BIGG Digital Assets Inc	0,0805 € (7,76%)	10k
E3O1Nexoptic Technology Corp	0,0055 € (-31,25%)	10,79k
YTRAurelia Metals	0,13 € (-23,08%)	4,5k
HK51Concord New Energy Group Limited	0,0405 € (-20,59%)	20k
S58Eureka Lithium Corp	0,0868 € (-20,37%)	9,07k
UH7ATennant Minerals NL	0,0035 € (-12,50%)	2,12k
DMLSayona Mining Limited	0,009 € (2,27%)	2,2M
PF8European Lithium Limited	0,031 € (6,90%)	1,36M
E3BEutelsat Communications	3,445 € (4,39%)	483,94k
A3YAltech Batteries Ltd	0,021 € (-1,87%)	320,1k
VODIVodafone Group plc	0,8708 € (-0,37%)	279,04k

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharming Group NV (PHGN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

PHGN Neueste Nachrichten

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders

Pharming Group to participate in June investor conferences

Pharming Group reports first quarter 2025 financial results and provides business update

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

Pharming Group to report first quarter 2025 financial results on May 8

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Pharming Group to participate in April investor conferences

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

PHGN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Pharming Group NV (PHGN) Börsenkurse

Pharming Group NV (PHGN)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

PHGN Neueste Nachrichten

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders

Pharming Group to participate in June investor conferences

Pharming Group reports first quarter 2025 financial results and provides business update

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

Pharming Group to report first quarter 2025 financial results on May 8

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Pharming Group to participate in April investor conferences

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

PHGN - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen